Surgalign Successfully Auctions Assets for $5.9M

“We are pleased to have concluded the sale process and believe with Xtant and Augmedics, our technology and its potential will live on."

I Stock 1415387406
iStock

Surgalign announced that following a competitive court-supervised marketing and sale process, including a competitive auction, the company has selected Xtant Medical as the successful bidder for its hardware and biologics assets and Augmedics as the successful bidder for its digital health assets.

The sale and marketing process, including the auction, was conducted in accordance with bidding procedures approved by the United States Bankruptcy Court for the Southern District of Texas, Houston Division, where the Company’s chapter 11 cases are currently pending. The Official Committee of Unsecured Creditors participated in the auction as a consultation party.

Xtant’s bid for the hardware and biologics assets consists of a cash purchase price of $5 million and the assumption of certain liabilities, as set forth in the asset purchase agreement. In addition, Augmedics’s bid for the digital health assets consists of a cash purchase price of $900,000 and the assumption of certain liabilities, as set forth in the asset purchase agreement. Both of the successful bidders’ bids maximize the value and minimize the remaining duration of the company’s chapter 11 proceedings by providing a clear path forward for the company to consummate a chapter 11 plan and return value to its stakeholders.

“We are pleased to have concluded the sale process and believe with Xtant and Augmedics, our technology and its potential will live on. I cannot thank our customers and partners enough for their support through this process. Further, I want to acknowledge the entire Surgalign team for their unwavering commitment throughout the years, and for their ongoing passion to develop the best solutions to help drive better patient outcomes," said Surgalign CEO Terry Rich.

The applicable asset purchase agreements between the Successful Bidders and the Company will be presented for approval to the Bankruptcy Court at the sale hearing set for August 8, 2023.

More